Tourmaline Bio Inc (TRML)

Tourmaline Bio Inc. is a pioneering biotechnology firm dedicated to developing cutting-edge cell therapies targeting severe and life-threatening conditions, with a particular emphasis on autoimmune disorders and oncology. Leveraging its proprietary technology platform, the company has established a robust pipeline of innovative therapies designed to meet critical unmet medical needs in the realm of precision medicine. With a strong commitment to scientific excellence and strategic collaborations, Tourmaline Bio is well-positioned to capitalize on transformative growth opportunities within the biopharmaceutical sector, making it an attractive investment prospect for institutional investors.